Thursday's Analysts' Upgrades and Downgrades

Who made what calls.
Author:
Publish date:

CHANGE IN RATINGS

Abbott Laboratories

(ABT) - Get Report

downgraded at Wachovia to Market Perform. Estimates also cut, as the company is facing several challenges at its key franchises.

Broadcom

initiated at UBS with Buy rating. Price target starts at $47 and FY 2008 EPS estimates set at $0.47.

BRE Properties

upgraded at Credit Suisse to Outperform from Neutral. Cites high portfolio quality at discounted valuation. Raised target price to $65 from $50.

Celestica

(CLS) - Get Report

upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Valuation call, as the stock is trading near tangible book value. Downside appears limited from current levels.

FirstFed Financial

downgraded at Friedman, Billings, Ramsey from Outperform to Market Perform. $50 price target. Credit costs will likely continue to rise. Share buybacks have yet to support the stock.

Marvell Technology

(MRVL) - Get Report

initiated with Neutral rating at UBS. Price target starts at $18 and FY 2009 EPS estimates set at $0.27.

Nuance Comm.

(NUAN) - Get Report

downgraded at Citigroup from Buy to Hold. Valuation call, as the stock is up 92% year-to-date. Fundamentals remain healthy.

Sandisk

(SNDK)

downgraded at Oppenheimer to Neutral. Advantages that the company has enjoyed will likely begin to unwind, heading into 2008.

TTM Technologies

(TTMI) - Get Report

downgraded at JP Morgan from Overweight to Neutral. Decline in the core business will not improve enough to move the stock higher in the near term. Estimates also cut.

Valueclick

(VCLK)

downgraded at Citigroup from Buy to Hold. Valuation call, as the stock is within 3% of the $30 price target.

Xyratex

(XRTX)

downgraded at Citigroup from Buy to Hold. $27 price target. Low-margin systems is the only business driver in the near term. Estimates also lowered.

STOCK COMMENTS / EPS CHANGES

Acergy

(ACGY)

numbers raised at Jefferies. Price target lifts to $36 from $34 and FY 2008 EPS estimates upped to $1.85 from $1.80. Reiterates Buy rating.

United Health

(UNH) - Get Report

numbers raised at Jefferies. Price target lifts to $52 from $48 and FY 2007 EPS estimates upped to $3.51 from $3.48. Reiterates Buy rating.

Coca-Cola

(KO) - Get Report

numbers boosted at Citigroup. Now seen reaching $67. Estimates also raised, because of improved fundamentals in the Japanese business. Buy rating.

Life Time Fitness

(LTM) - Get Report

target raised at UBS. New price objective jumps to $75 from $63. Reiterates Buy rating.

Ruby Tuesday

(RT)

target price cut at Credit Suisse to $22 from $30 based on "horrible" September results and outlook for next quarter. Believes there is value longer-term and reiterates Outperform rating.